Table of Contents
Print

Can Dopamine or Norepinephrine Measures Monitor ADHD Progress? 

Dopamine and norepinephrine play central roles in ADHD, influencing attention, behaviour, and emotional regulation. Given their importance, there is growing interest in using dopamine and norepinephrine measures to monitor ADHD progress over time. By tracking these neurochemicals, it may be possible to measure how well a patient is responding to treatment and whether interventions are effectively addressing the underlying neurochemical imbalances. 

Dopamine and Norepinephrine Measures for Treatment Tracking 

Neuroimaging techniques like PET scans and fMRI allow clinicians to measure dopamine and norepinephrine activity in the brain. Changes in the density of dopamine transporters or alterations in norepinephrine signalling could provide valuable insights into treatment tracking. For example, as patients undergo stimulant or non-stimulant medications, improvements in neurotransmitter function may be observed, signalling better symptom control and more efficient brain function. Longitudinal biomarkers which involve repeated measurements over time, could track the effectiveness of these treatments, providing data to inform medication adjustments. 

Limitations and Future Potential 

While these dopamine and norepinephrine measures show potential for monitoring ADHD progress, they are still largely used in research rather than clinical practice. The technology is costly, and the relationship between neurochemical activity and symptom improvement is not yet fully understood. Moreover, these measures are not always reliable for every individual, and the effectiveness of treatment may depend on various factors beyond neurochemical changes, such as environmental influences and cognitive strategies. 

Nevertheless, as research advances, dopamine and norepinephrine monitoring could become a key tool for personalised ADHD care, helping to fine-tune treatment plans for better outcomes. 

Visit providers like ADHD Certify for personal consultations to explore how dopamine and norepinephrine measures can aid in ADHD treatment tracking.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Dopamine and norepinephrine systems.

Victoria Rowe, MSc, author for my patient advice - mypatientadvice.co.uk

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.